|
Dataset ID |
Tissue / Organ |
Experiment type |
Sample |
Cell type |
Marker class |
Evidence |
|
GSE158142 (5dpf) |
brain, eye |
baseline |
5dpf, untreatment |
NA |
NA |
NA |
|
GSE158142 (8dpf) |
brain, eye |
baseline |
8dpf, untreatment |
NA |
NA |
NA |
|
GSE144944 (fgfr3 +|+) |
cranial vault |
baseline |
1mpf, fgfr3 +/+ |
NA |
NA |
NA |
|
GSE144944 (fgfr3 -|-) |
cranial vault |
growth |
1mpf, fgfr3 -/- |
NA |
NA |
NA |
|
GSE126647 (control) |
embryo |
baseline |
1.17dpf, control nkx2.5:ZsYellow+ cells |
NA |
NA |
NA |
|
PRJNA734348 (dome, control) |
embryo |
baseline |
4.3hpf, dome, oocyte microinjection with Rhodamine B and control MO at oogenesis III stage (GV) |
NA |
NA |
NA |
|
PRJNA564810 (1dpf) |
embryo |
baseline |
1dpf, a single-cell transcriptome atlas for zebrafish development |
NA |
NA |
NA |
|
GSE158142 (3dpf) |
head |
baseline |
3dpf, untreatment |
NA |
NA |
NA |
|
PRJNA415636 (pancreas, liver) |
hepatopancreas |
baseline |
adult, Zebrabow M, pancreas and liver |
NA |
NA |
NA |
|
GSE150498 (wildtype, untreated) |
intestine |
baseline |
6dpf, wildtype, untreated |
NA |
NA |
NA |
|
GSE150498 (nod2-|-, untreated) |
intestine |
disease |
6dpf, nod2-/-, untreated |
NA |
NA |
NA |
|
GSE150498 (wildtype, 1X DSS) |
intestine |
disease |
6dpf, wildtype, 1X DSS |
NA |
NA |
NA |
|
GSE150498 (nod2-|-, 1X DSS) |
intestine |
disease |
6dpf, nod2-/-, 1X DSS |
NA |
NA |
NA |
|
GSE150498 (wildtype, 2X DSS) |
intestine |
disease |
6dpf, wildtype, 2X DSS |
NA |
NA |
NA |
|
GSE150498 (wildtype, 2X DSS+BZA) |
intestine |
disease |
6dpf, wildtype, 2X DSS+BZA |
NA |
NA |
NA |
|
GSE150498 (nod2-|-, 2X DSS) |
intestine |
disease |
6dpf, nod2-/-, 2X DSS |
NA |
NA |
NA |
|
GSE150498 (nod2-|-, 2X DSS+BZA) |
intestine |
disease |
6dpf, nod2-/-, 2X DSS+BZA |
NA |
NA |
NA |
|
PRJNA668529 (3d) |
olfactory rosette |
disease |
3mpf, intranasal 100ng r-Spike 3 days |
NA |
NA |
NA |
|
GSE148591 (6mpf) |
pituitary |
baseline |
6mpf, male, Sox17:CreERT2 |
NA |
NA |
NA |
|
GSE148591 (3mpf) |
pituitary |
transplant |
3mpf, graft transplantation during early embryogenesis |
NA |
NA |
NA |
|
PRJNA415636 (primary pancreatic islet) |
primary pancreatic islet |
baseline |
adult, Zebrabow M, primary pancreatic islet |
NA |
NA |
NA |
|
GSE175929 (5mpf) |
retina |
baseline |
5mpf, GFP-positive cells collected from two transgenic zebrafish, Tg(rho:EGFP)ja2Tg and Tg(gnat2:EGFP)ja23Tg |
NA |
NA |
NA |
|
PRJNA551501 (2mpf) |
thyroid gland |
baseline |
2mpf, Tg(tg:mVenus-T2A-NTR) |
NA |
NA |
NA |
|
GSE131136 (all) |
trunk, skin |
baseline |
5dpf, sox10:CRE positive cells from 5dpf and post-embryonic zebrafish trunks with and without thyroid hormone |
NA |
NA |
NA |
|
GSE159709 (melanoma) |
tumor |
disease |
adult, equal numbers of sorted GFP+ (tumor) and GFP- (macroenvironment) cells |
NA |
NA |
NA |
|
PRJNA641144 (P_INV) |
tumor |
disease |
adult, ZMEL1-INV cells in vivo primary tumors |
NA |
NA |
NA |
|
PRJNA641144 (P_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vivo primary tumors |
NA |
NA |
NA |
|
PRJNA641144 (M_INV) |
tumor |
disease |
adult, ZMEL1-INV cells in vivo metastases |
NA |
NA |
NA |
|
PRJNA641144 (M_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vivo metastases |
NA |
NA |
NA |
|
PRJNA641144 (D_INV) |
tumor |
disease |
adult, ZMEL1-INV cells in vitro individual culture |
NA |
NA |
NA |
|
PRJNA641144 (D_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vitro individual culture |
NA |
NA |
NA |
|
PRJNA641144 (C_INV) |
tumor |
disease |
adult, ZMEL1-INV cells in vitro co-culture |
NA |
NA |
NA |
|
PRJNA641144 (C_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vitro co-culture |
NA |
NA |
NA |
|
GSE176129 (pdgfrb-positive) |
whole body |
baseline |
5dpf, FACS-isolated pdgfrb-positive cells |
NA |
NA |
NA |
|
GSE158099 (WT) |
whole body |
baseline |
16dpf, cd41:GFPlow-WT |
NA |
NA |
NA |
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
16dpf, cd41:GFPlow-runx1-/- |
NA |
NA |
NA |